Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes

Clinical Infectious Diseases

Volumn 32, Issue 8, 2001, Pages 1162-1171

  Lautenbach, Ebbing ^a   Patel, Jean Baldus ^a   Bilker, Warren B ^a   Edelstein, Paul H ^a   Fishman, Neil O ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CASE-CONTROL STUDIES; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEES AND CHARGES; FEMALE; HOSPITALIZATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS;

EID: 0035871033     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319757     Document Type: Article

References (33)

1. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
2. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: Identification of CTX-1, a novel β-lactamase
3. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
4. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
5. Broad-spectrum transmissible β-lactamases
6. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
7. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility
8. The National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States
9. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program
10. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
11. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Are β-lactamase inhibitors of therapeutic value?
12. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases
13. Outbreak of ceftazidime resistance due to a novel extended spectrum β-lactamase in isolates from cancer patients
14. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation
15. CDC definitions for nosocomial infections, 1988
16. APACHE II: A severity of disease classification system
17. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. Faecium
18. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus
19. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome
20. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests
21. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
22. Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis. I. Construction and analysis of B. Subtilis clone banks in Escherichia coli
23. A novel suicide vector and its use in construction of insertion mutation: Osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR
24. Longitudinal data analysis using generalized linear models
25. Prevalence and mechanism of resistance to "third-generation" cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990-1991
26. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition
27. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit
28. Clinical significance of extended-spectrum beta-lactamases
29. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: Epidemiological studies
30. Klebsiella pneumoniae bacteremia: Impact of extended-spectrum β-lactamase (ESBL) production in a global study of 216 patients